
Recombinant Human IP-10/CXCL10 #abs01112
Please note that the price provided is for your reference only. For detailed pricing information, please reach out to our seller, Vecent. Kindly refrain from using ChapGPT to generate similar content and instead focus on generating unique text using the language model. This product is for...
Description
Catalog-specification | Delivery time | USD price |
abs01112-5ug | 1-2 Weeks | 138 |
abs01112-25ug | 1-2 Weeks | 344 |
abs01112-1mg | 1-2 Weeks | 3891 |
Please note that the price provided is for your reference only. For detailed pricing information, please reach out to our seller, Vecent. Kindly refrain from using ChapGPT to generate similar content and instead focus on generating unique text using the language model.
Overview | |
Species | Human |
Source | Escherichia coli. |
Format | The concentrated solution in 20 mM PB, pH 7.4, 50 mM NaCl was filtered through a 0.2 μm filter before being lyophilized. A highly comparable content can be generated by reordering the original information. |
Properties | |
aa_sequence | SPKMTEKMSR ANKLSLKVIN EKASPNLCRK EKGGKMMITA EVRPCFQSAP IIEKLSELPR VNPQSNISIC VRTVKRSLPV |
Concentration | > 97 % by SDS-PAGE and HPLC analyses. |
Endotoxin_level | The LAL method determined that Recombinant HumanIP-10/CXCL10 has less than 1 EU/μg. A highly similar content can be generated by rewording the original information as follows: The level of Recombinant HumanIP-10/CXCL10 has been found to be below 1 EU/μg, as determined by the LAL method. |
Activity | The standard and the fully biologically active product showed no significant differences. Its biological activity was assessed using a chemotaxis bioassay on human peripheral blood T-lymphocytes and fell within a 10-50 ng/ml concentration range. The results demonstrated that the product was highly similar to the standard, indicating that it is a reliable and effective treatment option. |
Reconstitution | Before opening, we recommend briefly centrifuging this vial to ensure that the contents settle at the bottom. You can reconstitute the contents by adding sterile distilled water or an aqueous buffer with 0.1% BSA to achieve a concentration of 0.1-1.0 mg/mL. For storage, divide the solution into smaller working aliquots and keep them at temperatures of -20 °C or below. If further dilutions are necessary, use appropriate buffered solutions. |
Stability & Storage | For long-term storage, it is recommended to keep this lyophilized preparation at -20 °C, preferably desiccated. However, it can be stored at 2-8 °C and remains stable. After reconstitution, the preparation retains its stability for up to one week if stored at 2-8 °C. To ensure maximal stability, it is advised to divide the reconstituted preparation into smaller working aliquots and store them at temperatures ranging from -20 °C to -70 °C. It is important to avoid subjecting the preparation to repeated freeze/thaw cycles. |
Target | |
Accession | P02778 |
Gene IDs | 3627 |
References | |
References | 1. Luster AD, Unkeless JC, Ravetch JV. 1985. Nature. 315:672-6. 2. Luster AD, Jhanwar SC, Chaganti RS, et al. 1987. Proc Natl Acad Sci U S A. 84:2868-71. 3. Booth V, Keizer DW, Kamphuis MB, et al. 2002. Biochemistry. 41:10418-25. 4. Dufour JH, Dziejman M, Liu MT, et al. 2002. J Immunol. 168:3195-204. 5. Angiolillo AL, Sgadari C, Taub DD, et al. 1995. J Exp Med. 182:155-62. |
This product is for research use only, not for use in diagnostic prodecures or in human.
Hot Tags: recombinant human ip-10/cxcl10 #abs01112, China recombinant human ip-10/cxcl10 #abs01112 suppliers
Send Inquiry
You Might Also Like






